SenzaGen Subsidiary Wins SEK 2.8M VitroScreen Order
VitroScreen secured a SEK 2.8 million order from an existing global health and beauty ingredients supplier for non-animal efficacy studies, with testing starting immediately.
SenzaGen’s subsidiary VitroScreen secured a SEK 2.8M order from an existing global health and beauty ingredients supplier for non-animal efficacy studies, with testing starting immediately.Material DetailsContext by AI AnalystThis is a mid-cycle confirmation of recurring revenues in SenzaGen’s effi…